Citation
de Oliveira, Ana Paula Siqueira, et al. "Estrogenic and Chemopreventive Activities of Xanthones and Flavones of Syngonanthus (Eriocaulaceae)." Steroids, vol. 78, no. 11, 2013, pp. 1053-63.
de Oliveira AP, de Sousa JF, da Silva MA, et al. Estrogenic and chemopreventive activities of xanthones and flavones of Syngonanthus (Eriocaulaceae). Steroids. 2013;78(11):1053-63.
de Oliveira, A. P., de Sousa, J. F., da Silva, M. A., Hilário, F., Resende, F. A., de Camargo, M. S., Vilegas, W., dos Santos, L. C., & Varanda, E. A. (2013). Estrogenic and chemopreventive activities of xanthones and flavones of Syngonanthus (Eriocaulaceae). Steroids, 78(11), 1053-63. https://doi.org/10.1016/j.steroids.2013.07.002
de Oliveira AP, et al. Estrogenic and Chemopreventive Activities of Xanthones and Flavones of Syngonanthus (Eriocaulaceae). Steroids. 2013;78(11):1053-63. PubMed PMID: 23891669.
TY - JOUR
T1 - Estrogenic and chemopreventive activities of xanthones and flavones of Syngonanthus (Eriocaulaceae).
AU - de Oliveira,Ana Paula Siqueira,
AU - de Sousa,Juliana Ferreira,
AU - da Silva,Marcelo Aparecido,
AU - Hilário,Felipe,
AU - Resende,Flávia Aparecida,
AU - de Camargo,Mariana Santoro,
AU - Vilegas,Wagner,
AU - dos Santos,Lourdes Campaner,
AU - Varanda,Eliana Aparecida,
Y1 - 2013/07/25/
PY - 2013/03/05/received
PY - 2013/07/12/revised
PY - 2013/07/16/accepted
PY - 2013/7/30/entrez
PY - 2013/7/31/pubmed
PY - 2014/4/18/medline
KW - +S9
KW - 1
KW - 1,3,6,8-tetrahydroxy-2,5-dimethoxyxanthone
KW - 1,3,6,8-tetrahydroxy-5-methoxyxanthone
KW - 1,5,7-trihydroxy-3,6-dimethoxyxanthone
KW - 17β-estradiol
KW - 2
KW - 3
KW - 4
KW - 4-nitro-O-phenylenediamine, B[a]P, benzo[a]pyrene
KW - 5
KW - 6
KW - 6-hydroxyluteolin
KW - 7
KW - 7,3′-dimethoxyluteolin-6-C-β-glucopyranoside
KW - 7-methoxyluteolin-6-C-β-glucopyranoside
KW - 7-methoxyluteolin-8-C-β-glucopyranoside
KW - 8
KW - 9
KW - AFB(1)
KW - Antimutagenicity
KW - BAW
KW - CNPq
KW - Conselho Nacional de Desenvolvimento Científico e Tecnológico
KW - DES
KW - DMSO
KW - E(2)
KW - EEQ
KW - ER
KW - ER-RBA
KW - Eriocaulaceae
KW - Estrogenicity
KW - Ex-DCM
KW - Ex-Hex
KW - Ex-MeOH
KW - FAPESP
KW - Fundação de Amparo à Pesquisa do Estado de São Paulo
KW - HRT
KW - HSCCC
KW - I%
KW - MI
KW - Mutagenicity
KW - NPD
KW - Phytoestrogens
KW - RYA
KW - SA
KW - SD
KW - SERMs
KW - Sd
KW - Sm
KW - Sn
KW - Ss
KW - Standard Deviation
KW - UV
KW - aflatoxin B(1)
KW - dimethylsulfoxide
KW - estradiol equivalent
KW - estrogen diethylstilbestrol
KW - estrogen receptor
KW - estrogen receptor relative binding affinity
KW - hexane extract
KW - high speed counter current chromatography
KW - hormone replacement therapy
KW - luteolin
KW - methanol extract
KW - methanolic extract of capitula of Syngonanthus dealbatus
KW - methanolic extract of capitula of Syngonanthus macrolepsis
KW - methanolic extract of capitula of Syngonanthus nitens
KW - methanolic extract of capitula of Syngonanthus suberosus
KW - methylene chloride extract
KW - mix of A-1,3,6-trihydroxy-2-methoxyxanthone and B-1,3,6-trihydroxy-2,5-dimethoxyxanthone
KW - mutagenic index
KW - n-butanol, acetic acid and water solution
KW - percent of inhibition of reversion in bacterial strains
KW - recombinant yeast assay
KW - selective estrogen receptor modulators
KW - sodium azide, 2-AA, 2-anthramine, MMC, mitomycin C
KW - ultraviolet light
KW - with metabolization
KW - without metabolization
KW - −S9
SP - 1053
EP - 63
JF - Steroids
JO - Steroids
VL - 78
IS - 11
N2 - The possible benefits of some bioactive flavones and xanthones present in plants of the genus Syngonanthus prompted us to screen them for estrogenic activity. However, scientific research has shown that such substances may have undesirable properties, such as mutagenicity, carcinogenicity and toxicity, which restrict their use as therapeutic agents. Hence, the aim of this study was to assess the estrogenicity and mutagenic and antimutagenic properties. We used recombinant yeast assay (RYA), with the strain BY4741 of Saccharomyces cerevisiae, and Ames test, with strains TA100, TA98, TA97a and TA102 of Salmonella typhimirium, to evaluate estrogenicity, mutagenicity and antimutagenicity of methanolic extracts of Syngonanthus dealbatus (S.d.), Syngonanthus macrolepsis (S.m.), Syngonanthus nitens (S.n.) and Syngonanthus suberosus (S.s.), and of 9 compounds isolated from them (1=luteolin, 2=mix of A-1,3,6-trihydroxy-2-methoxyxanthone and B-1,3,6-trihydroxy-2,5-dimethoxyxanthone, 3=1,5,7-trihydroxy-3,6-dimethoxyxanthone, 4=1,3,6,8-tetrahydroxy-2,5-dimethoxyxanthone, 5=1,3,6,8-tetrahydroxy-5-methoxyxanthone, 6=7-methoxyluteolin-8-C-β-glucopyranoside, 7=7-methoxyluteolin-6-C-β-glucopyranoside, 8=7,3'-dimethoxyluteolin-6-C-β-glucopyranoside and 9=6-hydroxyluteolin). The results indicated the estrogenic potential of the S. nitens methanol extract and four of its isolated xanthones, which exhibited, respectively, 14.74±1.63 nM; 19.54±6.61; 7.20±0.37; 6.71±1.02 e 10.01±4.26 nM of estradiol-equivalents (EEQ). None of the extracts or isolated compounds showed mutagenicity in any of the test strains and all of them showed antimutagenic potential, in particular preventing mutations caused by aflatoxin B1 (AFB1) and benzo[a]pyrene (B[a]P). The results show that the xanthones, only isolated from the methanol extract of S. nitens capitula, probably were the responsible for its estrogenic activity and could be useful as phytoestrogens, providing a new opportunity to develop hormonal agents. In addition, flavones and xanthones could also be used as a new antimutagenic agent. Since, the mutagens are involved in the initiation and promotion of several human diseases, including cancer, the significance of novel bioactive phytocompounds in counteracting these pro-mutagenic and carcinogenic effects is now gaining credence.
SN - 1878-5867
UR - https://www.unboundmedicine.com/medline/citation/23891669/Estrogenic_and_chemopreventive_activities_of_xanthones_and_flavones_of_Syngonanthus__Eriocaulaceae__
DB - PRIME
DP - Unbound Medicine
ER -